Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ECLIPSE Trial - Ensure's Vascular Closure Device Speeds Hemostasis Trial

NCT00345631 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT00345631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00345631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ECLIPSE Trial - Ensure's Vascular Closure Device Speeds Hemostasis Trial
Lead sponsor
Cordis US Corp.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
September 30, 2007
Enrollment
488 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, transluminal, percutaneous coronary, coronary arteriosclerosis, peripheral arteriosclerosis